Trial Profile
Inhaled Nitric Oxide Gas Therapy in Mechanically Ventilated Patients with Severe Acute Respiratory Syndrome in COVID-19
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 07 May 2020
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Adult respiratory distress syndrome
- Focus Therapeutic Use
- 07 May 2020 New trial record
- 30 Apr 2020 According to a Mallinckrodt plc media release, this trial is being conducted at the Massachusetts General Hospital. Mallinckrodt plc is providing funding as well as INOmax (nitric oxide) gas to facilitate this study.